Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: Review and meta-analysis

被引:106
作者
Morgado, Manuel P. [1 ,2 ]
Morgado, Sandra R. [2 ]
Mendes, Liliana C. [1 ]
Pereira, Luisa J. [3 ]
Castelo-Branco, Miguel [1 ]
机构
[1] UBI, Hlth Sci Res Ctr, P-6200506 Covilha, Portugal
[2] HCCB, Covilha, Portugal
[3] UBI, Dept Math, P-6200506 Covilha, Portugal
关键词
Blood pressure; Compliance; Hypertension; Hypotensive agents; Interventions; Patients; Pharmacists; QUALITY-OF-LIFE; CARDIOVASCULAR RISK INTERVENTION; HYPERTENSION CONTROL; PRIMARY-CARE; MEDICATION ADHERENCE; PHARMACEUTICAL CARE; DIABETES-MELLITUS; ECONOMIC OUTCOMES; PATIENT OUTCOMES; RANDOMIZED-TRIAL;
D O I
10.2146/ajhp090656
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose. Pharmacist interventions to enhance blood pressure (BP) control and adherence to antihypertensive therapy in adults with essential hypertension were reviewed. Methods. A literature search was conducted to identify relevant articles describing pharmacist interventions intended to improve adherence to antihypertensive medications. Studies were included if they described a pharmacist intervention to improve medication adherence and analyzed adherence to therapy and BP control as outcomes. A fixed-effects model was used to combine data from randomized controlled trials. Results. A total of 15 studies were identified, testing 16 different interventions and containing data on 3280 enrolled patients. Although 87.5% of the interventions resulted in significant improvements in treatment outcomes, only 43.8% of the interventions were associated with significant increases in medication adherence. All interventions that increased antihypertensive medication adherence also significantly reduced BP. Almost all the interventions that were effective in increasing adherence to medication were complex, including combinations of different strategies. Meta-analysis of 2619 patients in 8 studies found that pharmacist interventions significantly reduced systolic blood pressure (SBP) (p < 0.001) and diastolic blood pressure (DBP) (p = 0.002) and that the meta-analytic differences in SBP and DBP changes from baseline to endpoint in intervention and control groups were -4.9 +/- 0.9 mm Hg (p < 0.001) and -2.6 +/- 0.9 mm Hg (p < 0.001), respectively. Conclusion. A literature review and meta-analysis showed that pharmacist interventions can significantly improve medication adherence, SBP, DBP, and BP control in patients with essential hypertension. Interventions were complex and multifaceted and included medication management in all analyzed studies.
引用
收藏
页码:241 / 253
页数:13
相关论文
共 70 条
[1]   2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension [J].
Afridi, I ;
Canny, J ;
Yao, CH ;
Christensen, B ;
Cooper, RS ;
Kadiri, S ;
Hill, S ;
Kaplan, N ;
Kuschnir, E ;
Lexchin, J ;
Mendis, S ;
Poulter, N ;
Psaty, BM ;
Rahn, KH ;
Sheps, SG ;
Whitworth, J ;
Yach, D ;
Bengoa, R ;
Ramsay, L ;
Kaplan, N ;
Mendis, S ;
Poulter, N ;
Whitworth, J .
JOURNAL OF HYPERTENSION, 2003, 21 (11) :1983-1992
[2]   Effect of pharmaceutical care programme on blood pressure and quality of life in a Nigerian pharmacy [J].
Aguwa, Cletus N. ;
Ukwe, Chinwe V. ;
Ekwunife, Obinna I. .
PHARMACY WORLD & SCIENCE, 2008, 30 (01) :107-110
[3]   OPERATING CHARACTERISTICS OF A BANK CORRELATION TEST FOR PUBLICATION BIAS [J].
BEGG, CB ;
MAZUMDAR, M .
BIOMETRICS, 1994, 50 (04) :1088-1101
[4]  
BLENKINSOPP A, 2000, J PHARM PRACT, V8, P165
[5]   Physician-pharmacist comanagement of hypertension: A randomized, comparative trial [J].
Borenstein, JE ;
Graber, G ;
Saltiel, E ;
Wallace, J ;
Ryu, S ;
Jackson, A ;
Deutsch, S ;
Weingarten, SR .
PHARMACOTHERAPY, 2003, 23 (02) :209-216
[6]   Patient compliance and blood pressure control on a nuclear-powered aircraft carrier: Impact of a pharmacy officer [J].
Brouker, ME ;
Gallagher, K ;
Larrat, EP ;
Dufresne, RL .
MILITARY MEDICINE, 2000, 165 (02) :106-110
[7]  
Bucci C, 2003, CAN J CARDIOL, V19, P391
[8]   The Asheville Project: Clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia [J].
Bunting, Barry A. ;
Smith, Benjamin H. ;
Sutherland, Susan E. .
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2008, 48 (01) :23-31
[9]  
Caro JJ, 1999, CAN MED ASSOC J, V160, P41
[10]  
Carter B L, 2009, Vnitr Lek, V55, P389